Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment
- Conditions
- Volume Deficit in the Mid-face
- First Posted Date
- 2021-06-15
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Prollenium Medical Technologies Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT04927052
- Locations
- 🇨🇦
Laser Rejuvenation, Calgary, Alberta, Canada
🇨🇦Alpha Research/Lucere Dermatology, Edmonton, Alberta, Canada
🇨🇦Dermetics, Burlington, Ontario, Canada
Safety and Effectiveness of PN40082 for Lip Augmentation
- Conditions
- Lip Augmentation
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Prollenium Medical Technologies Inc.
- Target Recruit Count
- 158
- Registration Number
- NCT04032977
- Locations
- 🇺🇸
Tennessee Clinical Research Center, Nashville, Tennessee, United States
A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation
- Conditions
- Lip Augmentation
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2021-07-14
- Lead Sponsor
- Prollenium Medical Technologies Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT04029519
- Locations
- 🇺🇸
California Dermatology & Clinical Research Institute, Encinitas, California, United States
🇺🇸International Dermatology Research, Inc, Miami, Florida, United States
🇺🇸Skin Specialists, PC, Omaha, Nebraska, United States
A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation
- Conditions
- Lip Augmentation
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2021-08-20
- Lead Sponsor
- Prollenium Medical Technologies Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT04029545
- Locations
- 🇺🇸
California Dermatology & Clinical Research Institute, Encinitas, California, United States
🇺🇸International Dermatology Research, Inc, Miami, Florida, United States
🇺🇸Skin Specialists, PC, Omaha, Nebraska, United States
Study to Evaluate Safety and Efficacy of Revanesse® Ultra + vs Revanesse® Ultra for Correction of NLF
- Conditions
- Nasolabial Fold Correction
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2019-04-11
- Lead Sponsor
- Prollenium Medical Technologies Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02991040
- Locations
- 🇺🇸
Tennessee Clinical Research Center, Nashville, Tennessee, United States
- Prev
- 1
- 2
- Next